Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonist finerenone in the management of diabetic kidney disease: A meta-analysis

2022; Medknow; Volume: 26; Issue: 3 Linguagem: Inglês

10.4103/ijem.ijem_376_21

ISSN

2230-9500

Autores

Deep Dutta, Vineet Surana, Saptarshi Bhattacharya, Sameer Aggarwal, Meha Sharma,

Tópico(s)

Blood Pressure and Hypertension Studies

Resumo

Data are scant on use of finerenone in diabetic kidney disease (DKD). We undertook this meta-analysis to address this knowledge gap.

Referência(s)